TLC BioSciences Corp. (TPEX:7924)
385.50
+33.00 (9.36%)
At close: Nov 6, 2026
| Market Cap | 51.49B |
| Revenue (ttm) | 78.44M -52.7% |
| Net Income | -1.82B |
| EPS | -18.95 |
| Shares Out | 133.56M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 331,550 |
| Open | 334.50 |
| Previous Close | 352.50 |
| Day's Range | 300.00 - 394.50 |
| 52-Week Range | 163.00 - 503.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |